Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie Sahler

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
NPJ Vaccines|December 17, 2022
Multivalent viral particles elicit safe and efficient immunoprotection against Nipah Hendra and Ebola virusesDuncan G Ithinji, David W Buchholz, Shahrzad Ezzatpour, et al.
Nature|March 28, 2022
A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeuticTirosh Shapira, I Abrrey Monreal, Sébastien P Dion, et al.
Plos Pathogens|March 31, 2025
Enhanced RNA replication and pathogenesis in recent SARS-CoV-2 variants harboring the L260F mutation in NSP6Taha Y Taha, Shahrzad Ezzatpour, Jennifer M Hayashi, et al.
Science Advances|August 27, 2025
Broad-spectrum synthetic carbohydrate receptors (SCRs) inhibit viral entry across multiple virus familiesShahrzad Ezzatpour, Khushabu Thakur, Kenneth Erzoah Ndede, et al.
Nature Communications|January 6, 2026
Sulfur-containing class of broad-spectrum antivirals improves influenza virus vaccine developmentDavid W Buchholz, Armando Pacheco, Sreetama Pal, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
NPJ Vaccines|December 17, 2022
Multivalent viral particles elicit safe and efficient immunoprotection against Nipah Hendra and Ebola virusesDuncan G Ithinji, David W Buchholz, Shahrzad Ezzatpour, et al.
Nature|March 28, 2022
A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeuticTirosh Shapira, I Abrrey Monreal, Sébastien P Dion, et al.
Plos Pathogens|March 31, 2025
Enhanced RNA replication and pathogenesis in recent SARS-CoV-2 variants harboring the L260F mutation in NSP6Taha Y Taha, Shahrzad Ezzatpour, Jennifer M Hayashi, et al.
Science Advances|August 27, 2025
Broad-spectrum synthetic carbohydrate receptors (SCRs) inhibit viral entry across multiple virus familiesShahrzad Ezzatpour, Khushabu Thakur, Kenneth Erzoah Ndede, et al.
Nature Communications|January 6, 2026
Sulfur-containing class of broad-spectrum antivirals improves influenza virus vaccine developmentDavid W Buchholz, Armando Pacheco, Sreetama Pal, et al.
Pageof 3